Risk is so high because Down syndrome usually involves a third copy of chromosome 21, which carries the amyloid precursor protein (APP) gene. That extra copy causes APP overexpression and excess beta-amyloid, the protein buildup that drives Alzheimer's pathology.
Alzheimer's disease damages memory and thinking through plaques and tangles that impair brain cells. In Down syndrome these changes appear decades early, with dementia symptoms commonly emerging in the 50s and 60s. According to the National Institute on Aging, nearly all adults with Down syndrome develop these brain changes by about age 40 NIA information on Alzheimer's in people with Down syndrome.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How the extra APP copy drives damage
- How high is risk and when does it appear?
- Why brain changes do not always mean dementia
- What baseline testing by 35 makes possible
How the extra APP copy drives damage
APP gives instructions for amyloid precursor protein, which the brain cuts into beta-amyloid fragments. With three copies, people make too much beta-amyloid. Excess fragments clump into plaques, while tau protein twists into tangles that impair brain-cell function.
Buildup starts very early, as early as the teens to 30s. The Lancet Neurology review reports Alzheimer's is now the leading cause of death in adults with Down syndrome over age 35 The Lancet Neurology review of Down syndrome and Alzheimer's. Decades of amyloid accumulation precede symptoms.
How high is risk and when does it appear?
At least half develop Alzheimer's dementia with age, with symptoms commonly appearing in the 50s and 60s as early-onset disease. The National Institute on Aging states this estimate in its genetics fact sheet NIA Alzheimer's disease genetics fact sheet.
Autopsy and clinical studies summarized by the Alzheimer's Association and the Horizon 21 consortium report higher lifetime risk, near 90 to 95 percent. About 30 percent are affected in their 50s and about 50 percent in their 60s. Dementia is typically diagnosed around ages 51 to 56.
Why brain changes do not always mean dementia
Brain pathology does not equal dementia. Many but not all people with plaques and tangles develop clinical dementia. This gap matters for families planning care.
Diagnosis is also imprecise because baseline intellectual disability varies from person to person. Other medical or psychiatric causes can cause decline, a problem the National Down Syndrome Society calls diagnostic overshadowing. Change must be judged against the person's own usual abilities, not a general cutoff.
What baseline testing by 35 makes possible
Clinicians are advised to document baseline cognition by about age 35 and track change over time. The Alzheimer's Association gives this guidance in its Down syndrome differential-diagnosis resource Alzheimer's Association guidance on differential diagnosis in Down syndrome. Baseline means a record of usual memory, thinking, daily skills, and behavior. The NIH-funded Alzheimer Biomarker Consortium-Down Syndrome program follows biomarkers to enable earlier detection and trials.
In its cohort of 167 adults ages 25 to 57, tau buildup and cognitive decline began on average 2.7 to 6.1 years after amyloid-PET positivity, meaning a scan showing amyloid. Mild impairment averaged 7.4 years after. Bring a list of current medicines, sleep changes, mood changes, and recent illness to each memory check. Ask the care team to compare new concerns directly against the age-35 baseline.
- Document baseline cognition by about age 35.
- Repeat the same checks over time to spot change.
- Rule out other medical or psychiatric causes before diagnosing dementia.
